Pyxis Oncology, Inc.
PYXSNasdaqCIK 1782223HealthcareFiscal year ends Dec 31
Reports and events: 96 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2120:27 ET | DEF 14A | Proxy statementPeriod 2026-10-21 | 0001193125-26-427882 |
| 2026-10-0121:24 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031767 |
| 2026-09-0911:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-385901 |
| 2026-09-0811:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-384386 |
| 2026-08-1311:44 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-347913 |
| 2026-08-1311:42 ET | 8-K | 2.02 Results of operations | 0001193125-26-347911 |
| 2026-07-0220:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001193125-26-294613 |
| 2026-06-1520:22 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-271137 |
| 2026-05-1411:56 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-222843 |
| 2026-05-1411:36 ET | 8-K | 2.02 Results of operations | 0001193125-26-222818 |
| 2026-04-3011:35 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001193125-26-194032 |
| 2026-04-3011:04 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-26-193940 |
| 2026-03-2311:17 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-118532 |
| 2026-03-2311:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-118525 |
| 2026-02-0621:07 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-26-041169 |
| 2025-12-1812:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-25-323704 |
| 2025-11-0312:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-261696 |
| 2025-11-0312:33 ET | 8-K | 2.02 Results of operations | 0001193125-25-261689 |
| 2025-08-1420:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108906 |
| 2025-08-1420:17 ET | 8-K | 2.02 Results of operations | 0000950170-25-108898 |
| 2025-08-0411:26 ET | 8-K | 8.01 Other events | 0000950170-25-101618 |
| 2025-07-0300:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-093456 |
| 2025-06-1820:17 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-087907 |
| 2025-05-1511:41 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071996 |
| 2025-05-1511:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-25-071992 |
| 2025-04-2911:41 ET | DEF 14A | Proxy statementPeriod 2025-04-29 | 0000950170-25-059573 |
| 2025-04-0201:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-049860 |
| 2025-03-2411:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-043491 |
| 2025-03-1812:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040771 |
| 2025-03-1811:57 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040767 |
| 2025-02-2612:39 ET | 8-K | 8.01 Other events | 0000950170-25-027330 |
| 2025-02-0412:40 ET | 8-K | 8.01 Other events | 0000950170-25-012846 |
| 2024-12-2323:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-24-139789 |
| 2024-12-1922:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-138563 |
| 2024-11-2021:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-129238 |
| 2024-11-1212:43 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124602 |
| 2024-11-1212:34 ET | 8-K | 2.02 Results of operations | 0000950170-24-124581 |
| 2024-10-2320:53 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-116698 |
| 2024-09-2520:08 ET | DEF 14A | Proxy statementPeriod 2024-09-25 | 0000950170-24-109337 |
| 2024-08-1420:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-097073 |
| 2024-08-1420:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-097054 |
| 2024-06-1220:17 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-072467 |
| 2024-06-1011:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-157911 |
| 2024-05-1412:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059099 |
| 2024-05-1411:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059093 |
| 2024-04-2620:15 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0000950170-24-049154 |
| 2024-04-0321:10 ET | SC 13D/A | Ownership report, active investor, amended | 0000950170-24-041264 |
| 2024-03-2720:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-037176 |
| 2024-03-2711:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-036822 |
| 2024-03-2121:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034868 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.